Eve Health Group Limited has released a press release.
Dyspro Prescribed to First Patients
Filed with ASX ·
6ix hasn’t read this filing yet.
EVE Health Group Limited on 6ix
In the deck
Earlier from EVE Health
- Eve Commences Distribution of Dyspro
- Appointment of Dr Fiona Cousins to Scientific Advisory Board
- Appendix 4E
- Aust Regulatory Path Cleared for ED & Dysmenorrhea Products
- EVE Submits First Commercial Purchase Order for Dyspro
Later from EVE Health
- EVE Raises $1.1m to Accelerate Launches of Dyspro and Libbo
- Medical Science Liaison Appointed
- EVE Signs Telehealth Services Agreement with hubMed
- EVE Signs Telehealth Services Agreement with hubMed -Revised
- EVE Completes Initial Production of Libbo
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health